Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Yingyi Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1046-6731; OpenAlex author ID A5083197519. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Dynamics of Circulating Tumor DNA (ctDNA) Predict Treatment Efficacy and Prognosis in Patients With Advanced Pancreatic Cancer: A Prospective Large-Cohort Stud… Last author DOI 10.1002/mco2.70829↗
  2. Adjuvant FOLFIRINOX versus S-1 monotherapy for resected PDAC: retrospective real-world data. Last author DOI 10.1177/17588359261470681↗
  3. S-1 plus oxaliplatin versus modified FOLFIRINOX for advanced pancreatic adenocarcinoma after gemcitabine plus nab-paclitaxel failure. Co-author DOI 10.1177/17588359251378698↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingting You · 3 shared papers, 2025–2026 · strength 0.88
  2. Yuejuan Cheng · 3 shared papers, 2025–2026 · strength 0.88
  3. Chunmei Bai · 3 shared papers, 2025–2026 · strength 0.88
  4. Hui Jun Tang · 2 shared papers, 2025–2026 · strength 0.59
  5. Dongfeng Song · 1 shared paper, 2026 · strength 0.29
  6. Hui Tang · 1 shared paper, 2026 · strength 0.29
  7. Huanwen Wu · 1 shared paper, 2025 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.